[Inhibiting effect of EGFR monoclonal antibody on proliferation of oral squamous cell carcinoma].
To investigate the inhibiting effect of epidermal growth factor receptor (EGFRmAb) on proliferation of oral squamous cell carcinoma (SCC). Tca8113 squamous cell carcinoma cell line was treated with different concentration of EGFRmAb. Cell growth curve, clone inhibition rate, cell cycle redistribution and the expression of p27kip1 were analyzed. EGFRmAb inhibited proliferation of oral SCC, leaded to elevation of cell proportion of G1phase cell, decreased the proportion of S phase cell and upregulated the express of p27kip1. EGFRmAb inhibited the proliferation of oral SCC, which related with G1 phase arrest of tumor cell.